Literature DB >> 11005520

Hybrid total hip arthroplasty with a precoated offset stem. Four to nine-year results.

V P Cannestra1, R A Berger, L R Quigley, J J Jacobs, A G Rosenberg, J O Galante.   

Abstract

BACKGROUND: Use of modern cementing techniques for fixation of femoral components in total hip arthroplasty has had excellent clinical and radiographic results in most patients. However, several authors have described early loosening of femoral components with roughened and precoated finishes. The purpose of this study was to examine the performance of the precoated Iowa stem, which has increased offset, and to compare the results with those of another cemented precoated femoral component with standard offset used at our institution.
METHODS: We carried out a prospective analysis of 102 primary hybrid total hip arthroplasties (a cementless acetabular component and a cemented femoral component) performed with use of the Iowa femoral component in ninety-five patients at our institution. The Iowa stem was used in hips that required greater offset than is available with standard stems as determined by preoperative templating. The average age of the patients at the time of the index procedure was sixty-nine years. Sixteen patients (seventeen hips) died before the forty-eight-month minimum follow-up period had elapsed. Two patients were lost to follow-up, and radiographic follow-up was incomplete for one. The mean duration of clinical and radiographic follow-up of the remaining eighty-two hips in the seventy-six surviving patients was sixty-five months (range, forty-eight to 104 months).
RESULTS: The average preoperative Harris hip score of 47 points (range, 16 to 69 points) improved to an average of 87 points (range, 24 to 100 points) at the time of the review. Two hips underwent femoral component revision. Four femoral stems were radiographically loose at an average of thirty-four months. Femoral osteolysis was seen in five hips (6 percent) at an average of fifty-four months postoperatively. No acetabular component was revised because of aseptic loosening. According to Kaplan-Meier analysis, the seven-year survival rate, with an end point of femoral revision, osteolysis, or stem debonding, was 90.6 percent (95 percent confidence interval, 0.87 to 0.94).
CONCLUSIONS: The prevalence of revision, osteolysis, and loosening after total hip arthroplasty with the Iowa femoral component at our institution was higher than that seen in our series of Harris Precoat stems, which had a survival rate of 98.4 percent (95 percent confidence interval, 0.97 to 1.00) at ten years with the same end points. The design of the Iowa stem may make it difficult to achieve a good cement mantle, and, in combination with the geometry and increased offset of the stem, may compromise the long-term survival of this cemented femoral component.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005520     DOI: 10.2106/00004623-200009000-00009

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  4 in total

1.  Fatigue debonding of the roughened stem-cement interface: effects of surface roughness and stem heating conditions.

Authors:  Leatha A Damron; Do-Gyoon Kim; Kenneth A Mann
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2006-07       Impact factor: 3.368

2.  Minimally invasive surgical approaches and traditional total hip arthroplasty: a meta-analysis of radiological and complications outcomes.

Authors:  Baohui Yang; Haopeng Li; Xijing He; Guoyu Wang; Siyue Xu
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

3.  [Femoral offset and hip functioning in total hip prosthesis].

Authors:  Abdelillah Rachid; Erraji Moncef; Abbassi Najib; Najib Abdeljaouad; Daudi Abdelkarim; Yacoubi Hicham
Journal:  Pan Afr Med J       Date:  2014-05-22

4.  Fifteen-year results of precoated femoral stem in primary hybrid total hip arthroplasty.

Authors:  Dong Hun Suh; Ho Hyun Yun; Sung Kwang Chun; Won Yong Shon
Journal:  Clin Orthop Surg       Date:  2013-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.